Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20063
20081
20093
20101
20121
20131
20142
20161
20172
20185
20191
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated8
Recruiting5
Unknown status4
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PhotoThera, Inc2
Acorda Therapeutics1
Bayer1
Burke Medical Research Institute1
CSL Behring1
Cerevast Therapeutics, Inc.1
Columbia University1
D-Pharm Ltd.1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke31
Stroke17
Atrial Fibrillation3
Ischemic Attack, Transient2
Myocardial Infarction2
Thrombosis2
Acute Coronary Syndrome1
Atherosclerosis1
Cardiovascular Diseases1
Cerebrovascular Disorders1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.